NEW CRYSTALLINE FORMS

Disclosed is the compound (2S)-1-{ (2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyacetyl} -N-[4-(N-methoxycarbamimidoyl)benzyl]azetidine-2- carboxamide in substantially crystalline anhydrate form having an X-ray powder diffraction pattern.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BENGTSSON, STEFAN, YMEN, BO, INGVAR, BERGMAN, GUDRUN, ANITA, ASLUND, BENGT, LEONARD, HOHLNEICHER, URSULA, RENATA, MARIA
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed is the compound (2S)-1-{ (2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyacetyl} -N-[4-(N-methoxycarbamimidoyl)benzyl]azetidine-2- carboxamide in substantially crystalline anhydrate form having an X-ray powder diffraction pattern.